Webster Financial CORP Form 4 insider transactions

Jason E. Schugel, Chief Risk Officer of Webster Financial Corp, reported a transaction in 830 shares of common stock on August 13, 2026.

Luis Massiani, President and COO of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Christopher J Motl, President, Commercial Banking of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Benjamin L. Krynick, Head of Bank Operations of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

William Neal Holland, EVP and CFO of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

James Mi Griffin, Head of Consumer Banking of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Javier L. Evans, Chief Human Resources Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

John R Ciulla, Chairman and CEO and a Director of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Elzbieta Cieslik, EVP & CAO of Bank of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Kristy Berner, EVP, GC & Corp Sec of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.

Kristen Antonopoulos, Chief Accounting Officer of Webster Financial Corp, reported a transaction in 1,158 shares of common stock on August 13, 2026.

William Neal Holland, EVP and CFO of Webster Financial Corp, reported a transaction in 2,428 shares of common stock on July 27, 2026.

Webster Financial Corp Director Mona Aboelnaga reported a transaction involving the donation of 1,500 shares of common stock to a charitable fund.

Maureen Mitchell, a Director at Webster Financial Corp, reported transactions involving common stock, including dividend reinvestments and a restricted stock grant.

Director William E. Whiston acquired 1,596 shares of Webster Financial Corp common stock via a restricted stock grant.

Director Lauren States acquired 1,596 shares of Webster Financial Corp common stock via a restricted stock grant.

Director Richard L. O'Toole was granted 1,596 shares of Webster Financial Corporation common stock as part of a restricted stock award.

Director Mark Pettie was granted 1,596 shares of Webster Financial Corp common stock as part of an equity compensation plan.

Director Laurence C. Morse acquired 1,596 shares of Webster Financial Corp common stock via a restricted stock grant.

Director Mona Aboelnaga acquired 1,596 shares of Webster Financial Corp common stock via a restricted stock grant.

Director Carol Hayles was granted 1,596 shares of Webster Financial Corporation common stock as part of a restricted stock award.

Webster Financial Corporation director William David Haas was granted 1,596 shares of common stock as part of a restricted stock award.

Webster Financial Corporation Director Frederick John Crawford was granted 1,596 shares of common stock as part of an equity compensation plan.

Director John P. Cahill acquired 1,596 shares of Webster Financial Corp common stock via a restricted stock grant.

Director William L. Atwell was granted 1,596 shares of restricted common stock in Webster Financial Corp.

Santander and Webster integration teams held a 'Walk the Walls' session to advance preparation for the acquisition closing, focusing on over 250 dependencies and 225 milestones.

Webster Financial Corp. Chairman and CEO John R. Ciulla sold 8,000 shares of common stock for $71.67 per share under a pre-arranged trading plan.

Webster Financial Corporation issues supplemental disclosures to its definitive proxy statement regarding the pending acquisition by Banco Santander to address stockholder litigation.

Richard L. O'Toole, a Director at Webster Financial Corp, reported a transaction involving a gift of 10,000 common shares to a charitable fund.

Webster Financial Corporation announces key leadership appointments for corporate functions within Santander US, effective post-acquisition by Banco Santander, S.A.